Pfizer Hetastarch Injectable

Pfizer's Hetastarch Injectable Hextend™ is a vital solution designed to aid in increasing blood plasma volume. Containing 6% Hetastarch in 0.9% Sodium Chloride, this injectable is meticulously formulated to expand plasma volume efficiently, crucial during critical medical situations. Whether for surgical, trauma, or emergency care settings, Hextend is essential for restoring necessary blood volume.

This product is packaged in 500 ml flexible containers, ensuring ease of use in any healthcare facility. Each case contains 12 such containers, facilitating adequate supply during high demand periods. The flexible packaging ensures safe storage and convenient handling. With its effective formula and practical packaging, Hextend is an indispensable resource for healthcare providers seeking reliable plasma expansion solutions.

• Contains 6% Hetastarch in 0.9% Sodium Chloride solution, facilitating effective plasma volume expansion.
• Packaged in a user-friendly 500 ml flexible container, aiding in ease of use and efficient storage.
• Delivered in cases of 12, suitable for hospital and clinical settings requiring bulk supply for frequent use.

• The Pfizer Hetastarch Injectable Hextend™ is primarily used as a plasma volume expander. It is designed to treat hypovolemia, which is a condition characterized by a decrease in blood volume.
• This injectable solution is also utilized in situations such as during surgeries, traumas, or burns where blood volume restoration is essential to maintain adequate circulation and organ function.

1. What is the concentration of Hetastarch in the Hextend solution?
The concentration of Hetastarch in the Hextend solution is 6g per 100 ml of solution.

2. What kind of container is the Hextend solution packaged in?
The Hextend solution is packaged in a 500 ml flexible container for easy administration and storage.

3. How many units come in a case for purchase?
A total of 12 flexible containers are included in each case.